Functional RECAP (REpair CAPacity) assay identifies homologous recombination deficiency undetected by DNA-based

Titia G Meijer1,2,3, Luan Nguyen4,5, Arne Van Hoeck4,5

  • 1Department of Molecular Genetics, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands. t.meijer@erasmusmc.nl.

Oncogene
|June 6, 2022
PubMed

Insights

The functional REpair CAPacity (RECAP) test identifies homologous recombination deficiency (HRD) tumors, including those not defined by DNA-based tests, suggesting broader utility for predicting Poly-[ADP-Ribose]-Polymerase inhibitor sensitivity in breast cancer patients.

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Germline BRCA1/2 mutations predict Poly-[ADP-Ribose]-Polymerase (PARP) inhibitor response in breast cancer (BC).
  • Homologous recombination repair deficient (HRD) tumors, even without germline BRCA1/2 mutations, may also respond to PARP inhibitors.
  • Various HRD biomarkers are being investigated for clinical validity and utility.

Purpose of the Study:

  • To evaluate if the functional REpair CAPacity (RECAP) test identifies a similar group of HRD tumors as DNA-based HRD tests.
  • To assess the concordance between the RECAP test and established DNA-based HRD classifiers.

Main Methods:

  • An HRD-enriched cohort of 71 breast cancer patients was selected using the RECAP test.
  • Patients underwent DNA-based HRD testing, including the Classifier of HOmologous Recombination Deficiency (CHORD) and BRCA1/2-like classifier.
  • Whole genome sequencing (WGS) was performed on a subset of samples.

Main Results:

  • The RECAP test identified all 15 bi-allelic BRCA deficient samples in the cohort.
  • RECAP status showed partial correlation with DNA-based HRD tests, with 70% concordance for both RECAP-CHORD and RECAP-BRCA1/2-like classifiers.
  • The RECAP test identified additional HRD samples not detected by DNA-based tests, suggesting it captures deficiencies in other DNA repair genes.

Conclusions:

  • The functional RECAP test identifies a significant proportion of HRD tumors, including those missed by DNA-based assays.
  • RECAP may identify additional patients who could benefit from PARP inhibitor therapy.
  • Further clinical trials are needed to compare HRD tests for optimal predictive value in clinical decision-making.

Related Concept Videos

Homologous Recombination02:31

Homologous Recombination

The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
52.9K
Long-patch Base Excision Repair01:02

Long-patch Base Excision Repair

Since the discovery of the two BER pathways, there has been a debate about how a cell chooses one pathway over the other and the factors determining this selection. Numerous in vitro experiments have pointed out multiple determinants for the sub-pathway selection. These are:
7.2K
Conservative Site-specific Recombination and Phase Variation02:53

Conservative Site-specific Recombination and Phase Variation

Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
6.2K
Restarting Stalled Replication Forks02:37

Restarting Stalled Replication Forks

DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart,...
5.9K
Base Excision Repair01:54

Base Excision Repair

One of the common DNA damages is the chemical alteration of single bases by alkylation, oxidation, or deamination. The altered bases cause mispairing and strand breakage during replication. This type of damage causes minimal change to the DNA double helix structure and can be repaired by the base excision repair (BER) pathways. BER corrects damaged DNA sequences by removing the damaged base and restoring the original base sequence using the complementary strand as a template.
The first step of...
23.0K